Back

Potential association between tafamidis and aortic stenosis progression in cardiac amyloidosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Degenerative left valve disease and left ventricle Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Ronak Patel

(United States of America)

4 More presentations in this session

Presentation thumbnail
Clinical characteristics and outcomes of left ventricular hypertrophy in severe primary mitral regurgitation
Mr H. Wong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Left ventricular myocardial work in degenerative mitral regurgitation and its impact on outcome
Doctor P. Turgeon (Quebec, CA)
Abstract Slides Video
Presentation thumbnail
Short-term left ventricular systolic dysfunction and long-term outcome in postsurgical patients with primary mitral regurgitation
Doctor X. Zhang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Work the stage: myocardial work and aortic valve stenosis cardiac damage staging independently predict all-cause mortality in patients undergoing transcatheter aortic valve replacement
Doctor Z. Ladanyi (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Degenerative left valve disease and left ventricle

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic significance of concomitant transthyretin cardiac amyloidosis and severe aortic stenosis: insights from a systematic review and meta-analysis
thumbnail
Congress Session
Improving risk stratification in aortic stenosis: from the valve to the ventricle
thumbnail
Congress Session
Advances in amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources